CYTOKINETICS INC — Director's Dealing 2022

Apr 7, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2022-04-04

Reporting Person: Jaw Ching (SVP Finance & CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-04-04	Common Stock	M	15000	$12.1	Acquired	82109	Direct
2022-04-04	Common Stock	S	15000	$40.0	Disposed	67109	Direct
2022-04-05	Common Stock	M	10000	$12.1	Acquired	77109	Direct
2022-04-05	Common Stock	S	10000	$42.0	Disposed	67109	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-04-04	Non-Qualified Stock Option (right to buy)	$12.1	M	15000	Disposed	2027-06-30	Common Stock (15000)	Direct
2022-04-05	Non-Qualified Stock Option (right to buy)	$12.1	M	10000	Disposed	2027-06-30	Common Stock (10000)	Direct

Footnotes

F1: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.